现代神经病理学背后的认知框架
本文讨论2021年WHO中枢神经系统肿瘤新分类在全球推广面临的挑战,指出其在资源匮乏的医疗环境中难以实施且专业神经病理医生稀缺。作者利用癌症基因组图谱(TCGA)低级别和高级别胶质瘤RNA测序数据,展示无监督机器学习技术的诊断应用,并讨论信息论量化如何优化病理工作流程。
要点
- 2021年WHO中枢神经系统肿瘤分类纳入现代检测手段,但全球推广受资源限制。
- 基于甲基化的分类无法解决神经病理学所有诊断问题。
- 信息论量化可生成聚焦的工作流程,避免不必要的检测并识别诊断生物标志物。
核心结论
- 基于甲基化的分类无法解决神经病理学全部诊断问题,信息论量化可优化诊断流程。
研究设计与样本
- 利用癌症基因组图谱(TCGA)低级别和高级别胶质瘤的RNA测序数据,展示无监督机器学习技术的诊断应用。
主要发现
- 2021年WHO中枢神经系统肿瘤分类在全球部署具有挑战性,在资源贫乏的医疗生态系统中不可行。
- 具备中枢神经系统肿瘤专业知识的神经病理学家非常稀少。
临床怎么用
- 信息论量化可生成聚焦的病理工作流程,防止开具不必要的检测并识别有助于诊断的生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: In 2021 the World Health Organization distributed a new classification of central nervous system tumors that incorporated modern testing modalities in the diagnosis. Although universally accepted as a scientifically superior system, this schema has created controversy because its deployment globally is challenging in the best of circumstances and impossible in resource-poor health care ecosystems. Compounding this problem is the significant challenge that neuropathologists with expertise in central nervous system tumors are rare. OBJECTIVE: To demonstrate diagnostic use of simple unsupervised machine learning techniques using publicly available data sets. I also discuss some potential solutions to the deployment of neuropathology classification in health care ecosystems burdened by this classification schema. DATA SOURCES: The Cancer Genome Atlas RNA sequencing data from low-grade and high-grade gliomas. CONCLUSIONS: Methylation-based classification will be unable to solve all diagnostic problems in neuropathology. Information theory quantifications generate focused workflows in pathology, resulting in prevention of ordering unnecessary tests and identifying biomarkers that facilitate diagnosis.
引用
- Otero JJ. The Cognitive Framework Behind Modern Neuropathology. Arch Pathol Lab Med. 2024. PMID: 37694567. doi:10.5858/arpa.2023-0209-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。